10 Best Robotics Stocks to Buy According to Billionaires

8. PROCEPT BioRobotics Corporation (NASDAQ:PRCT)

No. of Billionaire Investors: 10

No. of Hedge Fund Holders: 27

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is a commercial-stage company specializing in surgical robotics solutions for urology. The AquaBeam Robotic System is PROCEPT’s flagship product with an advanced image-guided system designed for minimally-invasive urologic surgeries.

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is heading in the right direction with a strong end to 2024. The company achieved a 65% year-over-year growth in revenue, posting $224.5 million. The company’s robot sales and procedures are attracting customers, especially in the U.S. The company achieved a 60% growth in the U.S. installed base, with 505 systems by the end of the year. Moreover, the company’s international revenue also spiked over 137% during Q4, driven by strong sales momentum in the U.K. In Q4, the gross margin reached an all-time high of 64%, thanks to improved operational efficiencies and higher average selling prices. The average selling price of PROCEPT’s systems was approximately $460,000 in 2024.

PROCEPT BioRobotics Corporation’s Hydro robotic system has been well-received, leading to a robust capital pipeline. The Hydro robotic system features advanced AI and ultrasound integration. With positive product developments and improved sales, the company expects its 2025 revenue to be around $320 million, a 43% increase compared to 2024.